Alnylam Pharmaceuticals, Inc. seeks a physician-scientist to lead clinical development across neurology and hematology RNAi programs.
The Director, Clinical Research will shape strategy, drive the plasminogen program from Phase 2 to 3, and serve as a primary spokesperson in regulatory discussions and scientific meetings. In a matrix organization, you will oversee trial conduct, safety, and regulatory submissions, collaborating with Preclinical, Regulatory Affairs and Medical Affairs to deliver
Director, Clinical Research - RNAi Therapeutics Leader in Maidenhead employer: Alnylam Pharmaceuticals, Inc.
At Alnylam, we pride ourselves on being an exceptional employer, offering a dynamic work culture that fosters collaboration and innovation in the field of biostatistics. Our Maidenhead office provides a hybrid working model, allowing for flexibility while ensuring strong team engagement. We are committed to employee growth, providing opportunities for professional development and involvement in cutting-edge clinical trials that make a meaningful impact on healthcare.
Contact Details:
Alnylam Pharmaceuticals, Inc. Recruitment Team
